50 results
8-K/A
EX-99.2
RNAC
Cartesian Therapeutics Inc
23 Jan 24
Independent Auditor’s Report
4:05pm
The estimated grant date fair values of employee stock option awards granted under the 2016 Plan were calculated using the Black-Scholes option pricing model
8-K/A
EX-99.1
RNAC
Cartesian Therapeutics Inc
23 Jan 24
Independent Auditor’s Report
4:05pm
the Black-Scholes option pricing model, based on the following range of assumptions:
Year Ended December 31,
Risk-free interest rate
Dividend yield
Expected
S-8
EX-99.2
c94yws9yy zhplt
12 Jan 24
Registration of securities for employees
4:16pm
8-K
EX-99.1
f0ftwnuf4c2a51wo
18 Nov 22
November 2022 Selecta Biosciences Corporate Presentation SELB
4:30pm
8-K
EX-99.1
n2yjp
4 Aug 22
August 2022 Selecta Biosciences Corporate Presentation SELB
8:05am
DEFR14A
mel69bir0bp8s8bg163n
3 May 22
Revised proxy
2:15pm
PRE 14A
rp6xahhqjcix5cta
22 Apr 22
Preliminary proxy
3:08pm